Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Said to Weigh Purchase of Strides Unit Agila Specialties
Bloomberg
Monday, January 14, 2013 - 12:28pm
tags:
Pfizer, M&A, Agila, Strides Arcolab, India, injectables
Is Tranzyme A Takeover Target For Bristol-Myers Squibb?
Seeking Alpha
Monday, January 14, 2013 - 12:28pm
tags:
M&A, Bristol-Myers Squibb, Tranzyme
Otsuka Can Block Generic Abilify as Court Rejects Appeal
Bloomberg
Monday, January 14, 2013 - 12:27pm
tags:
generics, Abilify, Otsuka, schizophrenia
Amgen Q4 Earnings Preview: A Banner 2013 For The King Of Biotech
Seeking Alpha
Monday, January 14, 2013 - 12:26pm
tags:
earnings, Amgen
GSK files for U.S. approval of new diabetes drug
Reuters
Monday, January 14, 2013 - 12:04pm
tags:
GSK, diabetes, albiglutide
JPMorgan Healthcare Conference Rewind: Rigel Pharmaceuticals
Motley Fool
Monday, January 14, 2013 - 12:01pm
tags:
JPMHC 2013, Rigel Pharmaceuticals
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Monday, January 14, 2013 - 12:00pm
tags:
JNJ, diabetes, FDA, canagliflozin
[video]Dendreon: 3 Areas You Must Watch
Motley Fool
Monday, January 14, 2013 - 11:59am
tags:
Dendreon, Provenge
AbbVie Deserves A Chance
Seeking Alpha
Monday, January 14, 2013 - 11:58am
tags:
AbbVie, Abbott Laboratories
The Soft Underbelly of ZIOPHARM Oncology
Motley Fool
Monday, January 14, 2013 - 11:57am
tags:
Ziopharm
Novartis Earnings: How Will They Grow?
Motley Fool
Monday, January 14, 2013 - 10:35am
tags:
earnings, Novartis
4 Can't-Miss Health-Care Events to Watch For This Week
Motley Fool
Monday, January 14, 2013 - 10:26am
tags:
Santarus, Uceris, Zecuity, NuPathe, Forest Labs
William Blair Analysts Are Gaining Comfort Ahead Of Dynavax's Heplisav PDUFA
Seeking Alpha
Monday, January 14, 2013 - 10:18am
tags:
Dynavax, Heplisav, hepatitis B
1 Great Dividend You Can Buy Right Now
Motley Fool
Saturday, January 12, 2013 - 11:17am
tags:
JNJ
Is Teva Just Looking Out for Itself
Motley Fool
Saturday, January 12, 2013 - 11:14am
tags:
Teva, Copaxone, multiple sclerosis, MS, generics, Biogen, BG-12
Man Taking Generic Drug Can Sue Branded Maker
NY Times
Saturday, January 12, 2013 - 11:13am
tags:
generics, lawsuits
AbbVie recalling thyroid drug
Yahoo/AP
Saturday, January 12, 2013 - 11:11am
tags:
AbbVie, Synthroid, thyroid, recalls
Merck Pulls the Plug
Motley Fool
Saturday, January 12, 2013 - 11:06am
tags:
Merck, Tredaptive, cholesterol
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Saturday, January 12, 2013 - 11:05am
tags:
JNJ, canagliflozin, diabetes, type 2 diabetes
J&J's Prostate Cancer Drug Zytiga Approved for Earlier Use in EU
Motley Fool
Saturday, January 12, 2013 - 11:04am
tags:
JNJ, Zytiga, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.